| Trial ID: | L0798 |
| Source ID: | NCT03467282
|
| Associated Drug: |
Probiotic
|
| Title: |
Effect of Probiotic Supplementation in Nonalcoholic Steatohepatitis Patients: Randomized Clinical Trial - PROBILIVER TRIAL
|
| Acronym: |
NASH
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease
|
| Interventions: |
Dietary Supplement: Probiotic;Dietary Supplement: Placebo
|
| Outcome Measures: |
hepatic fibrosis;cardiovascular riskdiversity of gut microbiota;inflammation by TLR4 expression;inflammation by CK18 expression;inflammation by serum C-reactive protein;metabolic syndrome;change in body composition by DEXA;body composition by bioimpedance;change in hand grip strength;change in physical ability;change in the parameters of sarcopenia by serum myostatin;change in the parameters of sarcopenia by serum testosterone
|
| Sponsor/Collaborators: |
Hospital de Clinicas de Porto Alegre
|
| Gender: |
All
|
| Age: |
18 Years80 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
46
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
|
| Start Date: |
09/03/2018
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
Brazil
|
| URL: |
https://clinicaltrials.gov/show/NCT03467282
|
